| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/15/2007 | US7217427 Polymersomes and related encapsulating membranes |
| 05/15/2007 | US7217423 Revitalising active complex for the skin |
| 05/15/2007 | US7217422 Compositions and methods for enhancing corticosteroid delivery |
| 05/15/2007 | US7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis |
| 05/15/2007 | US7217409 Suspension stabilizing agents for pharmaceutical aerosols |
| 05/15/2007 | US7217381 Systems, methods and apparatuses for manufacturing dosage forms |
| 05/15/2007 | US7217351 Valve for controlling flow of a fluid |
| 05/15/2007 | CA2366186C Retinoid antagonists and use thereof |
| 05/15/2007 | CA2294337C Preparation of pharmaceutical compositions |
| 05/15/2007 | CA2268455C Methods and apparatus for treatment of parkinson's disease |
| 05/15/2007 | CA2266811C Method and composition for wound treatment |
| 05/15/2007 | CA2215258C Method of making a pressure sensitive skin adhesive sheet material |
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/10/2007 | WO2007053810A2 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein |
| 05/10/2007 | WO2007053612A2 High viscosity diutan gums and methods of producing |
| 05/10/2007 | WO2007053608A2 Films and capsules made from modified carboxymethycellulose materials and methods of making same |
| 05/10/2007 | WO2007053533A2 Sodium chloride solution for drug reconstitution or dilution |
| 05/10/2007 | WO2007053424A2 Silicone vesicles containing actives |
| 05/10/2007 | WO2007053393A2 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 05/10/2007 | WO2007053392A2 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 05/10/2007 | WO2007053179A1 Dry limited use cloth |
| 05/10/2007 | WO2007053134A1 A method for normalizing insulin levels |
| 05/10/2007 | WO2007053076A1 A method for preparing a textile material and a textile material thus prepared and produced |
| 05/10/2007 | WO2007052877A1 An enteric sustained-release tablet comprising paroxetine |
| 05/10/2007 | WO2007052802A1 Reduced coenzyme q10-containing composition which is stable against oxidation, and method for stabilization of reduced coenzyme q10 |
| 05/10/2007 | WO2007052793A1 Patch |
| 05/10/2007 | WO2007052629A1 Oligo double-stranded rna and pharmaceutical composition |
| 05/10/2007 | WO2007052592A1 Pharmaceutical preparation having excellent photostability |
| 05/10/2007 | WO2007052357A1 Isosorbide preparation |
| 05/10/2007 | WO2007052307A2 Stable solid oral dosage forms of valsartan |
| 05/10/2007 | WO2007052167A2 Stable composition for a pharmaceutical formulation containing olanzapine |
| 05/10/2007 | WO2007052164A2 A pharmaceutical formulation containing olanzapine |
| 05/10/2007 | WO2007052076A2 Formulations comprising jorumycin-, reni eramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 05/10/2007 | WO2007052042A2 A hollow fibre-based biocompatible drug delivery device with one or more layers |
| 05/10/2007 | WO2007052003A1 Sealed tablet |
| 05/10/2007 | WO2007051918A1 Stabilized dry compositions, method for obtaining them and use thereof |
| 05/10/2007 | WO2007051743A2 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound |
| 05/10/2007 | WO2007051476A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 05/10/2007 | WO2007051358A1 HYDROXYPROPYL-SULFOBUTYL-β-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF |
| 05/10/2007 | WO2007051303A1 MODIFIED siRNA MOLECULES AND USES THEREOF |
| 05/10/2007 | WO2007035940A3 Transdermal norelgestromin delivery system |
| 05/10/2007 | WO2007033372A3 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| 05/10/2007 | WO2007032993A3 Surfactant systems for delivery of organic compounds |
| 05/10/2007 | WO2007030754A3 Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| 05/10/2007 | WO2007028758A3 Method for the production of soft capsule envelopes based on polyvinyl alcohol-polyethylene glycol graft polymers |
| 05/10/2007 | WO2007022113A3 Solid dosage forms of valsartan and amlodipine and method of making the same |
| 05/10/2007 | WO2007020262A3 Chocolate coated spherical filled capsules |
| 05/10/2007 | WO2007020260A3 Pancreatin micropellet cores suitable for enteric coating |
| 05/10/2007 | WO2007020259A3 Controlled release pharmaceutical compositions for acid labile drugs |
| 05/10/2007 | WO2007008389A3 Use of color changing indicators in consumer products |
| 05/10/2007 | WO2007002880A3 Method of enhanced drug application |
| 05/10/2007 | WO2007002238A3 Drug/polymer composite materials and methods of making the same |
| 05/10/2007 | WO2007001979A9 Medicament delivery article, accessory & system |
| 05/10/2007 | WO2006135434A3 Semi-soft c-class immunostimulatory oligonucleotides |
| 05/10/2007 | WO2006129095A3 Sustained release preparations of pro-insulin c-peptide |
| 05/10/2007 | WO2006122828A3 Optimized injection formulation for rna |
| 05/10/2007 | WO2006102395A3 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 05/10/2007 | WO2006102177A3 Biomarkers for efficacy of aliskiren as a hypertensive agent |
| 05/10/2007 | WO2006094974A3 Chemically defined stabiliser composition |
| 05/10/2007 | WO2006085336A3 Stabilized anthracycline glycoside pharmaceutical compositions |
| 05/10/2007 | WO2005069750A3 Therapeutic composition with nanoscale activation agents |
| 05/10/2007 | WO2005041855A3 Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof |
| 05/10/2007 | US20070106328 Retrieval devices for anchored cardiovascular sensors |
| 05/10/2007 | US20070106281 Remote controller for in situ reaction device |
| 05/10/2007 | US20070106280 Implantable pump with reservoir level detector |
| 05/10/2007 | US20070106279 Remote controlled in situ reaction device |
| 05/10/2007 | US20070106278 Intraocular iontophoretic device and associated methods |
| 05/10/2007 | US20070106277 Remote controller for substance delivery system |
| 05/10/2007 | US20070106276 In situ reaction device |
| 05/10/2007 | US20070106275 Reaction device controlled by RF control signal |
| 05/10/2007 | US20070106274 Control systems for implantable medical devices |
| 05/10/2007 | US20070106273 Remote controlled in vivo reaction method |
| 05/10/2007 | US20070106272 Remote controlled in situ reaction method |
| 05/10/2007 | US20070106271 Remote control of substance delivery system |
| 05/10/2007 | US20070106270 Substance delivery system |
| 05/10/2007 | US20070106269 Remotely controlled substance delivery device |
| 05/10/2007 | US20070106268 Remote controlled in vivo reaction method |
| 05/10/2007 | US20070106267 Reaction device controlled by magnetic control signal |
| 05/10/2007 | US20070106266 Remote controlled in situ reation method |
| 05/10/2007 | US20070106199 Implantable pump apparatuses |
| 05/10/2007 | US20070106064 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/10/2007 | US20070105956 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 05/10/2007 | US20070105912 Pharmaceutical compositions comprising lercanidipine |
| 05/10/2007 | US20070105818 Water solubility, bioavailability, oral administration; unit dosage |
| 05/10/2007 | US20070105815 Biocompatible poly-beta-1-4-N-acetylglucosamine |
| 05/10/2007 | US20070105799 Codon-optimized polynucleotide-based vaccines against Bacillus anthracis infection |
| 05/10/2007 | US20070104860 Initiated chemical vapor deposition of vinyl polymers for the encapsulation of particles |
| 05/10/2007 | US20070104796 Use of xenon with hypothermia for treating neonatal asphyxia |
| 05/10/2007 | US20070104795 Multiphase active ingredient formulation |
| 05/10/2007 | US20070104794 Enzyme granules |
| 05/10/2007 | US20070104793 Process for making ceramic, mineral, and metal beads from powder |
| 05/10/2007 | US20070104792 Nanoparticulate tadalafil formulations |
| 05/10/2007 | US20070104791 Method of preparing a pharmaceutical composition and pharmaceutical compositions obtainable thereby |
| 05/10/2007 | US20070104790 Mesoporous compositions for use in drug delivery |
| 05/10/2007 | US20070104789 Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone |
| 05/10/2007 | US20070104788 Once-daily administration of central nervous system drugs |
| 05/10/2007 | US20070104787 Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances |
| 05/10/2007 | US20070104786 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 05/10/2007 | US20070104785 Tablets of linezolid form iii and processes for their preparation |
| 05/10/2007 | US20070104784 Compositions and methods of treatment comprising amoxicillin and potassium clavulante with xanthan |